Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 1 |
2011 | 1 |
2014 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
Parkinsonism Relat Disord. 2022 Mar;96:65-73. doi: 10.1016/j.parkreldis.2022.01.022. Epub 2022 Feb 8.
Parkinsonism Relat Disord. 2022.
PMID: 35227940
Free article.
Clinical Trial.
Serotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO).
Panisset M, Chen JJ, Rhyee SH, Conner J, Mathena J; STACCATO study investigators.
Panisset M, et al.
Pharmacotherapy. 2014 Dec;34(12):1250-8. doi: 10.1002/phar.1500. Epub 2014 Oct 14.
Pharmacotherapy. 2014.
PMID: 25314256
Item in Clipboard
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease.
Watts RL, Lyons KE, Pahwa R, Sethi K, Stern M, Hauser RA, Olanow W, Gray AM, Adams B, Earl NL; 228 Study Investigators.
Watts RL, et al.
Mov Disord. 2010 May 15;25(7):858-66. doi: 10.1002/mds.22890.
Mov Disord. 2010.
PMID: 20461803
Clinical Trial.
Item in Clipboard
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
Hauser RA, Panisset M, Abbruzzese G, Mancione L, Dronamraju N, Kakarieka A; FIRST-STEP Study Group.
Hauser RA, et al.
Mov Disord. 2009 Mar 15;24(4):541-50. doi: 10.1002/mds.22343.
Mov Disord. 2009.
PMID: 19058133
Clinical Trial.
Item in Clipboard
Immediate versus delayed switch from levodopa/carbidopa to levodopa/carbidopa/entacapone: effects on motor function and quality of life in patients with Parkinson's disease with end-of-dose wearing off.
Lew MF, Somogyi M, McCague K, Welsh M; Lce QoL Study Group.
Lew MF, et al.
Int J Neurosci. 2011 Nov;121(11):605-13. doi: 10.3109/00207454.2011.598982. Epub 2011 Aug 16.
Int J Neurosci. 2011.
PMID: 21843110
Clinical Trial.
Item in Clipboard
Cite
Cite